Literature DB >> 15499214

Osteopontin and calcium stone formation.

Jack G Kleinman1, Jeffrey A Wesson, Jeremy Hughes.   

Abstract

Osteopontin (OPN) is a phosphorylated protein of wide tissue distribution that is found in association with dystrophic calcification including in the organic matrix of kidney stones. It is a strong inhibitor of crystal formation and growth in vitro, but there is still debate regarding its effects upon crystal adhesion to tubular epithelial cells. In this brief review, we will outline the evidence implicating OPN in stone disease with the primary emphasis being on the interaction of OPN with calcium oxalate (CaOx), the major constituent of calcium containing stones. Finally, preliminary data is presented regarding the amounts and features of OPN present in the urine of stone formers and normal individuals. Copyright (c) 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499214     DOI: 10.1159/000080263

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  27 in total

1.  The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells.

Authors:  Lauren A Thurgood; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2011-09-20

2.  Role of osteopontin in early phase of renal crystal formation: immunohistochemical and microstructural comparisons with osteopontin knock-out mice.

Authors:  Masahito Hirose; Keiichi Tozawa; Atsushi Okada; Shuzo Hamamoto; Yuji Higashibata; Bin Gao; Yutaro Hayashi; Hideo Shimizu; Yasue Kubota; Takahiro Yasui; Kenjiro Kohri
Journal:  Urol Res       Date:  2011-08-11

3.  Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein.

Authors:  Yan Liu; Lan Mo; David S Goldfarb; Andrew P Evan; Fengxia Liang; Saeed R Khan; John C Lieske; Xue-Ru Wu
Journal:  Am J Physiol Renal Physiol       Date:  2010-06-30

4.  Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine.

Authors:  Bernd Grohe; Brian P H Chan; Esben S Sørensen; Gilles Lajoie; Harvey A Goldberg; Graeme K Hunter
Journal:  Urol Res       Date:  2011-01-14

5.  Oxalate toxicity in renal cells.

Authors:  Julie A Jonassen; Yasuo Kohjimoto; Cheryl R Scheid; Madelyn Schmidt
Journal:  Urol Res       Date:  2005-11-13

6.  Mass spectroscopic characteristics of low molecular weight proteins extracted from calcium oxalate stones: preliminary study.

Authors:  Wen-Chi Chen; Chien-Chen Lai; Chein-Cheng Lai; Yuhsin Tsai; Yu-Hsin Tsai; Wei-Yong Lin; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 7.  Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall's plaques.

Authors:  Xue-Ru Wu
Journal:  Urolithiasis       Date:  2014-08-06       Impact factor: 3.436

8.  Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals.

Authors:  Adam Taller; Bernd Grohe; Kem A Rogers; Harvey A Goldberg; Graeme K Hunter
Journal:  Biophys J       Date:  2007-05-11       Impact factor: 4.033

9.  Analysis of HK-2 cells exposed to oxalate and calcium oxalate crystals: proteomic insights into the molecular mechanisms of renal injury and stone formation.

Authors:  Shushang Chen; Xiaofeng Gao; Yinghao Sun; Chuanliang Xu; Linhui Wang; Tie Zhou
Journal:  Urol Res       Date:  2009-10-28

10.  High calcium concentration and calcium oxalate crystals cause significant inaccuracies in the measurement of urinary osteopontin by enzyme linked immunosorbent assay.

Authors:  Lauren A Thurgood; Phulwinder K Grover; Rosemary Lyons Ryall
Journal:  Urol Res       Date:  2008-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.